September 12th 2024
Researchers reported several factors and indicators that may predict early-stage systemic sclerosis among patients in Japan.
The subsequent MAD portion of the study has commenced dosing. Results are anticipated in Q4.
A recent reviewed showed that self-stigma in patients with skin disease is influenced by body image issues and social support.
September 11th 2024
New study results show promise in dupilumab for bullous pemphigoid, with 59% of patients avoiding disease relapse.
These positive data will support US regulatory submission by end of 2024.